Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis
Open Access
- 1 November 2022
- journal article
- review article
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 48 (6) , 915-929
Abstract
This study aimed to explore the prevalence and clinical risk factors in patients diagnosed with incidental prostate cancer (IPC) during certain surgeries (transurethral resection of the prostate [TURP], open prostatectomy [OP], and holmium laser enucleation of the prostate [HoLEP]) after clinically suspected benign prostatic hyperplasia (BPH). Literature search of the MEDILINE, Web of Science, Embase, and Cochrane Library databases was performed to identify eligible studies published before June 2021. Multivariate adjusted odds ratios (ORs) and associated 95% confidence intervals (CIs) of the prevalence and clinical risk factors of IPC were calculated using random or fixed-effect models. Twenty-three studies were included in the meta-analysis. Amongst the 94.783 patients, IPC was detected in 24.715 (26.1%). Results showed that the chance of IPC detection (10%, 95% CI: 0.07-4.00; P<0.001; I2=97%) in patients treated with TURP is similar to that of patients treated with HoLEP (9%, 95% CI: 0.07-0.11; P<0.001; I2=81.4%). However, the pooled prevalence estimate of patients treated with OP was 11% (95% CI: −0.03-0.25; P=0.113; I2=99.1%) with no statistical significance. We observed increased incidence of IPC diagnosis after BPH surgery amongst patients with higher prostate-specific antigen (PSA) level (OR: 1.13, 95% CI: 1.04-1.23; P=0.004; I2=89%), whereas no effect of age (OR: 1.02, 95% CI: 0.97-1.06; P=0.48; I2=78.8%) and prostate volume (OR: 0.99, 95% CI: 0.96-1.03; P=0.686; I2=80.5%) were observed. The prevalence of IPC was similar amongst patients undergoing TURP, HoLEP, and OP for presumed BPH. Interestingly, increased PSA level was the only independent predictor of increasing risk of IPC after BPH surgery rather than age and prostate volume. Hence, future research should focus on predictors which accurately foretell the progression of prostate cancer to determine the optimal treatment for managing patients with IPC after BPH surgery.Keywords
This publication has 42 references indexed in Scilit:
- Preoperative Clinical Factors for Diagnosis of Incidental Prostate Cancer in the Era of Tissue-Ablative Surgery for Benign Prostatic Hyperplasia: A Korean Multi-Center ReviewKorean Journal of Urology, 2012
- Incidental prostate cancer revisited: Early outcomes after holmium laser enucleation of the prostateInternational Journal of Urology, 2011
- Derivatives of prostate‐specific antigen as predictors of incidental prostate cancerBJU International, 2009
- Outcome of radical prostatectomy for incidental carcinoma of the prostateBJU International, 2009
- Incidental Prostate Cancer Detected by Cystoprostatectomy in Korean MenUrology, 2009
- Incidence and mortality of incidental prostate cancer: a Swedish register-based studyBritish Journal of Cancer, 2008
- Practice Patterns in Benign Prostatic Hyperplasia Surgical Therapy: The Dramatic Increase in Minimally Invasive TechnologiesJournal of Urology, 2008
- Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has decreased in the PSA eraProstate Cancer and Prostatic Diseases, 2008
- Radical Prostatectomy After Previous Prostate Surgery: Clinical and Functional OutcomesJournal of Urology, 2006
- Holmium Laser Enucleation Versus Transurethral Resection of the Prostate. Are Histological Findings Comparable?Journal of Urology, 2004